Am. J. Respir. Crit. Care Med., Volume 164, Number 10, November 2001, 1948-1956

Lung Tissue Eosinophils May Be Cleared Through Luminal Entry Rather Than Apoptosis
Effects of Steroid Treatment

LENA ULLER, CARL G. A. PERSSON, LEIF KÄLLSTRÖM, and JONAS S. ERJEFÄLT

Departments of Physiological Sciences and Clinical Pharmacology, University Hospital, Lund, Sweden; and AstraZeneca R & D, Lund, Sweden

Spontaneous or steroid-induced eosinophil apoptosis occurring in vitro has not been demonstrated in lung tissues in vivo. This study examines cell apoptosis in rat lungs using the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate (dUTP) nick end labeling (TUNEL) technique and transmission electron microscopy (TEM). After establishing sustained lung edema and eosinophilia by challenge with Sephadex beads intratracheally, budesonide treatment was started intratracheally. Sephadex alone increased the total number of apoptotic cells, which were not efficiently engulfed by macrophages or other cells, in vivo. Yet apoptotic tissue eosinophils were exceedingly rare (1 of 360 TEM-analyzed eosinophils). By contrast, approximately 20% of eosinophils in the airway lumen were apoptotic, and unengulfed. Budesonide promptly inhibited edema but 3 d of steroid treatment were required to reduce the established tissue eosinophilia. Not at any time point did budesonide induce eosinophil apoptosis (0 of 318 TEM-analyzed tissue eosinophils). We conclude that (1) eosinophil apoptosis can occur but is a rare event in vivo in respiratory tract tissues; (2) airway tissue eosinophils, rather than undergoing apoptosis, are eliminated by migration into airway lumen followed by apoptosis and mucociliary clearance; (3) anti-inflammatory steroid treatment may not increase eosinophil apoptosis in vivo nor may it affect the luminal entry of eosinophils; (4) steroids permit elimination of eosinophils into airway lumen and slowly resolve established lung eosinophilia.

This article has been cited by other articles:

				L. C. Kottyan, A. R. Collier, K. H. Cao, K. A. Niese, M. Hedgebeth, C. G. Radu, O. N. Witte, G. K. Khurana Hershey, M. E. Rothenberg, and N. Zimmermann Eosinophil viability is increased by acidic pH in a cAMP- and GPR65-dependent manner Blood, September 24, 2009; 114(13): 2774 - 2782. [Abstract] [Full Text] [PDF]

				E. J. Saude, I. P. Obiefuna, R. L. Somorjai, F. Ajamian, C. Skappak, T. Ahmad, B. K. Dolenko, B. D. Sykes, R. Moqbel, and D. J. Adamko Metabolomic Biomarkers in a Model of Asthma Exacerbation: Urine Nuclear Magnetic Resonance Am. J. Respir. Crit. Care Med., January 1, 2009; 179(1): 25 - 34. [Abstract] [Full Text] [PDF]

				J. C. Porter, M. Falzon, and A. Hall Polarized Localization of Epithelial CXCL11 in Chronic Obstructive Pulmonary Disease and Mechanisms of T Cell Egression J. Immunol., February 1, 2008; 180(3): 1866 - 1877. [Abstract] [Full Text] [PDF]

				R. L. Sorkness, K. M. Herricks, R. J. Szakaly, R. F. Lemanske Jr, and L. A. Rosenthal Altered allergen-induced eosinophil trafficking and physiological dysfunction in airways with preexisting virus-induced injury Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L85 - L91. [Abstract] [Full Text] [PDF]

				S. Y. Leung, A. Niimi, A. Noble, T. Oates, A. S. Williams, S. Medicherla, A. A. Protter, and K. F. Chung Effect of Transforming Growth Factor-beta Receptor I Kinase Inhibitor 2,4-Disubstituted Pteridine (SD-208) in Chronic Allergic Airway Inflammation and Remodeling J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 586 - 594. [Abstract] [Full Text] [PDF]

				K. Rydell-Tormanen, L. Uller, and J. S. Erjefalt Direct evidence of secondary necrosis of neutrophils during intense lung inflammation Eur. Respir. J., August 1, 2006; 28(2): 268 - 274. [Abstract] [Full Text] [PDF]

				K. F. Rabe, E. Pizzichini, B. Stallberg, S. Romero, A. M. Balanzat, T. Atienza, P. A. Lier, and C. Jorup Budesonide/Formoterol in a Single Inhaler for Maintenance and Relief in Mild-to-Moderate Asthma: A Randomized, Double-Blind Trial. Chest, February 1, 2006; 129(2): 246 - 256. [Abstract] [Full Text] [PDF]

				E F M Wouters, D S Postma, B Fokkens, W C J Hop, J Prins, A F Kuipers, H R Pasma, C A J Hensing, E C Creutzberg, and for the COSMIC (COPD and Seretide: a Multi-Center Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial Thorax, June 1, 2005; 60(6): 480 - 487. [Abstract] [Full Text] [PDF]

				M. G. Belvisi Regulation of Inflammatory Cell Function by Corticosteroids Proceedings of the ATS, November 1, 2004; 1(3): 207 - 214. [Abstract] [Full Text] [PDF]

				L. Uller, M. Andersson, L. Greiff, C. G. A. Persson, and J. S. Erjefalt Occurrence of Apoptosis, Secondary Necrosis, and Cytolysis in Eosinophilic Nasal Polyps Am. J. Respir. Crit. Care Med., October 1, 2004; 170(7): 742 - 747. [Abstract] [Full Text] [PDF]

				J S Erjefalt, L Uller, M Malm-Erjefalt, and C G Persson Rapid and efficient clearance of airway tissue granulocytes through transepithelial migration Thorax, February 1, 2004; 59(2): 136 - 143. [Abstract] [Full Text] [PDF]

				C.J.A. Duncan, A. Lawrie, M.G. Blaylock, J.G. Douglas, and G.M. Walsh Reduced eosinophil apoptosis in induced sputum correlates with asthma severity Eur. Respir. J., September 1, 2003; 22(3): 484 - 490. [Abstract] [Full Text] [PDF]

				C. G. A. Persson Rebuttal from Dr. Persson Am. J. Respir. Crit. Care Med., July 1, 2002; 166(1): 8 - 8. [Full Text] [PDF]

				M. J. TOBIN Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 598 - 618. [Full Text] [PDF]